<p>The SRLS shows approximately linear release of lidocaine for more than the 7 d administration period in this clinical study. The fraction of lidocaine released from the SRLS relative to the actual lidocaine content in the SRLS is shown as the mean±standard deviation (n = 4).</p
BackgroundTumescent lidocaine anesthesia consists of subcutaneous injection of relatively large volu...
The kinetics of the elimination of lidocaine upon discontinuation of lidocaine infusions lasting mor...
International audiencePurposeTumescent lidocaine anesthesia (TLA) is an opportunity to perform maste...
<p>In vitro drug release rate (µg/day) measured from (a) drug/lipid, 0.04 and (b) drug/lipid, 0.11, ...
<p>(A) Plain lidocaine data predicted by Model B (i.e. with two asynchronous first-order absorption ...
The deep-tissue penetration of lidocaine below a dermally applied site was quantified in a rat model...
The mechanisms of time-related reduction in lidocaine clearance were studied using a “one-pass ” per...
Recently, lidocaine topical systems utilizing nonaqueous matrices have been developed and provide ef...
<p>Cumulative latanoprost release (%) from DPPC LUVs loaded with varying amount of drug/lipid mole r...
The pharmacokinetics of intravenously administered lidocaine were studied in 10 normal subjects, 11 ...
Background: We have synthesized a sustained-release lidocaine sheet (SRLS) using biodegradable polym...
BACKGROUNDWe have synthesized a sustained-releaselidocaine sheet (SRLS) and injectable sustained-rel...
BACKGROUND:We have synthesized a sustained-release lidocaine sheet (SRLS) using biodegradable polyme...
<p>SH-SY5Y cells were either pretreated with the indicated concentrations of NNC 55-0396 dihydrochlo...
The effect of the chemical nature of the drug on matrix degradation and drug release behavior of deg...
BackgroundTumescent lidocaine anesthesia consists of subcutaneous injection of relatively large volu...
The kinetics of the elimination of lidocaine upon discontinuation of lidocaine infusions lasting mor...
International audiencePurposeTumescent lidocaine anesthesia (TLA) is an opportunity to perform maste...
<p>In vitro drug release rate (µg/day) measured from (a) drug/lipid, 0.04 and (b) drug/lipid, 0.11, ...
<p>(A) Plain lidocaine data predicted by Model B (i.e. with two asynchronous first-order absorption ...
The deep-tissue penetration of lidocaine below a dermally applied site was quantified in a rat model...
The mechanisms of time-related reduction in lidocaine clearance were studied using a “one-pass ” per...
Recently, lidocaine topical systems utilizing nonaqueous matrices have been developed and provide ef...
<p>Cumulative latanoprost release (%) from DPPC LUVs loaded with varying amount of drug/lipid mole r...
The pharmacokinetics of intravenously administered lidocaine were studied in 10 normal subjects, 11 ...
Background: We have synthesized a sustained-release lidocaine sheet (SRLS) using biodegradable polym...
BACKGROUNDWe have synthesized a sustained-releaselidocaine sheet (SRLS) and injectable sustained-rel...
BACKGROUND:We have synthesized a sustained-release lidocaine sheet (SRLS) using biodegradable polyme...
<p>SH-SY5Y cells were either pretreated with the indicated concentrations of NNC 55-0396 dihydrochlo...
The effect of the chemical nature of the drug on matrix degradation and drug release behavior of deg...
BackgroundTumescent lidocaine anesthesia consists of subcutaneous injection of relatively large volu...
The kinetics of the elimination of lidocaine upon discontinuation of lidocaine infusions lasting mor...
International audiencePurposeTumescent lidocaine anesthesia (TLA) is an opportunity to perform maste...